Promedius
PrivateLast Round
Series B
Jun 5, 2026
Total Funding Raised
$25.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Promedius operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series B round in June 2026.
Promedius is a healthtech company that provides an AI-powered platform using chest X-ray images to screen for osteoporosis and assist in diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Promedius Comparables
Compare Promedius with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BeamWorks Inc. | 84% | |
| AZmed | 82% | |
| DeepRad AI | 81% |
For institutional investors. Book with your work email.
Promedius Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 5, 2026 | ||||
| Grant | Sep 16, 2025 | ||||
| Series A Extension | Mar 12, 2024 | ||||
| Series A Extension | Oct 21, 2021 | ||||
| Grant | Sep 1, 2020 | ||||
Seed | Jun 30, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Promedius Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SL Investment | Series B |
| CNT Tech | Grant |
| Stassets Investment | Series A Extension |
| Korea Investment Partners | Series A Extension |
| STASSETS INVESTMENT | Series B, Series A Extension |
| Woori Venture Partners Co., Ltd. | Series B, Series A Extension |
| Bigbang Angels, Inc. | Grant, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2026
$14.15M round with participation from Naver Corporation.
- Jan 1, 2026
Launched Osteo Signal, an AI for osteoporosis screening from chest X-rays.
For institutional investors. Book with your work email.
Promedius Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Promedius's valuation, stock price, and market status.
Is Promedius a public or private company?
Promedius is a private company.
What is the current stock price of Promedius?
Promedius is a private company, so its shares have no public market price. Caplight tracks Promedius's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Promedius worth (valuation)?
Valuation information for Promedius is not publicly available.
Can I buy Promedius stock?
Promedius shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Promedius's last funding round?
Promedius's most recent funding round was Series B on June 5, 2026.
Who are the main investors in Promedius?
Key investors in Promedius include Stassets Investment, STASSETS INVESTMENT.
Will Promedius IPO soon?
No public IPO plans have been announced for Promedius.
How can I track Promedius secondary market activity?
Caplight tracks bids, offers, and trades in Promedius's shares on secondary markets.